Sugar and Kidneys: How New Pills Help

You have two tough health issues: type 2 diabetes (T2D) and chronic kidney disease (CKD). Doctors are finding new ways to treat these conditions, especially with a special kind of pill called an SGLT2 inhibitor. These pills are getting lots of attention in Europe, Japan, and the US. The FOUNTAIN study (NCT05526157) looked at adults with both T2D and CKD who started taking these pills before a new one called finerenone hit the market. The study tried to figure out how well these pills work and if patients stick to their treatment plan. Treatment adherence, which means taking your medicine as prescribed, is super important in managing these conditions. The study found that many patients did well with the new pills, but there were still some challenges with sticking to the treatment. One interesting thing the study showed is that how well patients do might depend on where they live. This means that understanding local healthcare systems and cultural differences can play a big role in managing these complex diseases. In summary, SGLT2 inhibitors are a promising new tool for managing T2D and CKD, but there's still work to be done to help patients use them effectively.